Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Little

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cell Host & Microbe|December 16, 2023
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infectionChristopher J Lehmann, Nicholas P Dylla, Matthew Odenwald, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Gastro Hep Advances|June 27, 2025
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver DiseaseMatthew A Odenwald, Ramanujam Ramaswamy, Huaiying Lin, et al.
Nature Metabolism|June 23, 2026
Host metabolism can produce many indoles and phenols independently of the microbiomeJenna E AbuSalim, Kellen Olszewski, Salma Youssef, et al.
Science Advances|June 4, 2025
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortalityAlexander P de Porto, Nicholas P Dylla, Matthew Stutz, et al.
Nature Communications|November 4, 2022
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failureMatthew R Stutz, Nicholas P Dylla, Steven D Pearson, et al.
Circulation. Heart Failure|October 30, 2019
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical CenterLauren A Eberly, Aaron Richterman, Anne G Beckett, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cell Host & Microbe|December 16, 2023
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infectionChristopher J Lehmann, Nicholas P Dylla, Matthew Odenwald, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Gastro Hep Advances|June 27, 2025
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver DiseaseMatthew A Odenwald, Ramanujam Ramaswamy, Huaiying Lin, et al.
Nature Metabolism|June 23, 2026
Host metabolism can produce many indoles and phenols independently of the microbiomeJenna E AbuSalim, Kellen Olszewski, Salma Youssef, et al.
Science Advances|June 4, 2025
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortalityAlexander P de Porto, Nicholas P Dylla, Matthew Stutz, et al.
Nature Communications|November 4, 2022
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failureMatthew R Stutz, Nicholas P Dylla, Steven D Pearson, et al.
Circulation. Heart Failure|October 30, 2019
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical CenterLauren A Eberly, Aaron Richterman, Anne G Beckett, et al.
Pageof 3